Latest Breaking News On - Gen announces topline results - Page 1 : comparemela.com

FibroGen Announces Topline Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer

FibroGen Announces Topline Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesMeichiel keenanDavid deluciaDeyaa adibRahul aggarwalExchange commissionDrug administrationAmerican society for clinical oncologyChina health authorityCorporate communicationsFibrogen incGen announces topline resultsMetastatic castration resistant prostateFortis therapeutics sponsored phaseChief medical officerCalifornia san francisco

FibroGen Announces Topline Results from LELANTOS-2, a Phase 3 Clinical Study of Pamrevlumab in Ambulatory Duchenne Muscular Dystrophy

FibroGen Announces Topline Results from LELANTOS-2, a Phase 3 Clinical Study of Pamrevlumab in Ambulatory Duchenne Muscular Dystrophy
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

David deluciaMichael szumeraFibrogen incExchange commissionDrug administrationGen announces topline resultsAmbulatory duchenne muscularNorth star ambulatory assessmentThane wettigInterim chief executive officerAbout duchenne muscular dystrophyOrphan drug designationFast trackRare pediatric disease designationAnnual reportQuarterly report